Buy Or Sell Opportunity • Jun 05
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 12% to US$67.20. The fair value is estimated to be US$84.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.3% over the last 3 years. Earnings per share has declined by 37%. For the next 3 years, revenue is forecast to grow by 0.3% per annum. Earnings are forecast to decline by 6.9% per annum over the same time period. Recent Insider Transactions • May 14
Independent Director recently bought US$999k worth of stock On the 8th of May, Aaron Regent bought around 14k shares on-market at roughly US$68.93 per share. This transaction amounted to 61% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$2.0m more in shares than they have sold in the last 12 months. Declared Dividend • May 11
First quarter dividend of US$0.55 announced Shareholders will receive a dividend of US$0.55. Ex-date: 30th June 2026 Payment date: 17th July 2026 Dividend yield will be 3.2%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 8 years and payments have been stable during that time. EPS is expected to decline by 15% over the next 3 years. However, it would need to fall by 51% to increase the payout ratio to a potentially unsustainable range. Reported Earnings • May 07
First quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behind First quarter 2026 results: EPS: US$0.27 (up from US$0.022 in 1Q 2025). Revenue: US$5.80b (up 19% from 1Q 2025). Net income: US$131.0m (up US$120.0m from 1Q 2025). Profit margin: 2.3% (up from 0.2% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 9.7%. Earnings per share (EPS) missed analyst estimates by 47%. Revenue is forecast to stay flat during the next 3 years compared to a 5.2% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Buy Or Sell Opportunity • May 06
Now 23% undervalued Over the last 90 days, the stock has risen 8.6% to US$73.81. The fair value is estimated to be US$96.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.0% per annum. Earnings are forecast to decline by 2.1% per annum over the same time period. Duyuru • Apr 10
Nutrien Ltd. to Report Q1, 2026 Results on May 06, 2026 Nutrien Ltd. announced that they will report Q1, 2026 results After-Market on May 06, 2026 Buy Or Sell Opportunity • Apr 08
Now 21% undervalued Over the last 90 days, the stock has risen 25% to US$74.88. The fair value is estimated to be US$94.95, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.1% per annum. Earnings are forecast to decline by 1.9% per annum over the same time period. Upcoming Dividend • Mar 24
Upcoming dividend of US$0.55 per share Eligible shareholders must have bought the stock before 31 March 2026. Payment date: 16 April 2026. Payout ratio is a comfortable 47% and this is well supported by cash flows. Trailing yield: 2.9%. Lower than top quartile of American dividend payers (4.4%). Higher than average of industry peers (1.8%). Buy Or Sell Opportunity • Mar 20
Now 20% undervalued Over the last 90 days, the stock has risen 20% to US$74.73. The fair value is estimated to be US$93.65, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.0% per annum. Earnings are forecast to decline by 0.9% per annum over the same time period. New Risk • Mar 18
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 0.9% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Recent Insider Transactions • Mar 17
Insider recently sold US$403k worth of stock On the 11th of March, Christopher Reynolds sold around 5k shares on-market at roughly US$83.96 per share. This transaction amounted to 37% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought US$328k more than they sold in the last 12 months. New Risk • Mar 13
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 1.5% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Buy Or Sell Opportunity • Mar 04
Now 21% undervalued Over the last 90 days, the stock has risen 23% to US$73.59. The fair value is estimated to be US$92.91, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.6% per annum. Earnings are forecast to decline by 0.02% per annum over the same time period. Duyuru • Feb 23
Nutrien Ltd., Annual General Meeting, May 06, 2026 Nutrien Ltd., Annual General Meeting, May 06, 2026. Declared Dividend • Feb 22
Fourth quarter dividend of US$0.55 announced Shareholders will receive a dividend of US$0.55. Ex-date: 31st March 2026 Payment date: 16th April 2026 Dividend yield will be 3.1%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is covered by both earnings (47% earnings payout ratio) and cash flows (53% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 8 years and payments have been stable during that time. EPS is expected to decline by 5.2% over the next 3 years. However, it would need to fall by 48% to increase the payout ratio to a potentially unsustainable range. Reported Earnings • Feb 19
Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2025 results: EPS: US$4.66 (up from US$1.36 in FY 2024). Revenue: US$25.9b (up 3.7% from FY 2024). Net income: US$2.27b (up 236% from FY 2024). Profit margin: 8.7% (up from 2.7% in FY 2024). The increase in margin was primarily driven by higher revenue. Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) exceeded analyst estimates by 9.0%. Revenue is forecast to grow 1.3% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance. New Risk • Feb 04
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 0.5% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.5% per year for the foreseeable future. Minor Risk High level of debt (49% net debt to equity). New Risk • Jan 21
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 0.6% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.6% per year for the foreseeable future. Minor Risk High level of debt (49% net debt to equity). Board Change • Jan 21
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Independent Director Julie Lagacy was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Duyuru • Jan 21
Nutrien Ltd. to Report Q4, 2025 Results on Feb 18, 2026 Nutrien Ltd. announced that they will report Q4, 2025 results After-Market on Feb 18, 2026 Duyuru • Dec 12
Adecoagro S.A. (NYSE:AGRO) completed the acquisition of 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR). Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million on September 8, 2025. The transaction is subject to customary closing conditions and is expected to be completed before the end of 2025.
Rabo Trading Argentina SA acted as financial advisor for Adecoagro S.A. BofA Securities, Inc. acted as financial advisor for Nutrien Ltd.
Adecoagro S.A. (NYSE:AGRO) completed the acquisition of 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) on December 10, 2025. Buy Or Sell Opportunity • Oct 16
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 6.0% to US$56.42. The fair value is estimated to be US$71.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Earnings per share has declined by 82%. For the next 3 years, revenue is forecast to grow by 2.2% per annum. Earnings are also forecast to grow by 14% per annum over the same time period. Duyuru • Oct 07
Nutrien Ltd. to Report Q3, 2025 Results on Nov 05, 2025 Nutrien Ltd. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 05, 2025 Upcoming Dividend • Sep 22
Upcoming dividend of US$0.55 per share Eligible shareholders must have bought the stock before 29 September 2025. Payment date: 17 October 2025. Payout ratio is on the higher end at 78%, however this is supported by cash flows. Trailing yield: 3.8%. Lower than top quartile of American dividend payers (4.4%). Higher than average of industry peers (2.0%). Duyuru • Sep 09
Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million. Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million on September 8, 2025. The transaction is subject to customary closing conditions and is expected to be completed before the end of 2025.
Rabo Trading Argentina SA acted as financial advisor for Adecoagro S.A. BofA Securities, Inc. acted as financial advisor for Nutrien Ltd. Board Change • Sep 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. Independent Director Julie Lagacy was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Declared Dividend • Aug 10
Second quarter dividend of US$0.55 announced Shareholders will receive a dividend of US$0.55. Ex-date: 29th September 2025 Payment date: 17th October 2025 Dividend yield will be 3.9%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is covered by both earnings (78% earnings payout ratio) and cash flows (63% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 33% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Aug 07
Second quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind Second quarter 2025 results: EPS: US$2.51 (up from US$0.78 in 2Q 2024). Revenue: US$10.2b (up 2.8% from 2Q 2024). Net income: US$1.22b (up 217% from 2Q 2024). Profit margin: 12% (up from 3.9% in 2Q 2024). The increase in margin was primarily driven by lower expenses. Revenue missed analyst estimates by 2.4%. Earnings per share (EPS) exceeded analyst estimates by 10%. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 67 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Aug 06
Now 20% undervalued Over the last 90 days, the stock has risen 5.8% to US$57.95. The fair value is estimated to be US$72.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 73%. For the next 3 years, revenue is forecast to grow by 2.4% per annum. Earnings are also forecast to grow by 23% per annum over the same time period. Duyuru • Jul 10
Nutrien Ltd. to Report Q2, 2025 Results on Aug 06, 2025 Nutrien Ltd. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025 Upcoming Dividend • Jun 23
Upcoming dividend of US$0.55 per share Eligible shareholders must have bought the stock before 30 June 2025. Payment date: 18 July 2025. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 3.6%. Lower than top quartile of American dividend payers (4.8%). Higher than average of industry peers (2.2%). Declared Dividend • May 11
First quarter dividend of US$0.55 announced Shareholders will receive a dividend of US$0.55. Ex-date: 30th June 2025 Payment date: 18th July 2025 Dividend yield will be 3.9%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (202% earnings payout ratio) nor is it covered by cash flows (127% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 125% to bring the payout ratio under control. EPS is expected to grow by 108% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio. New Risk • May 09
New major risk - Dividend sustainability The dividend is not well covered by earnings and cash flows. Payout ratio: 202% Cash payout ratio: 127% Dividend yield: 3.9% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 202% Cash payout ratio: 127% Minor Risks High level of debt (52% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.1% net profit margin). Reported Earnings • May 08
First quarter 2025 earnings: EPS and revenues miss analyst expectations First quarter 2025 results: EPS: US$0.022 (down from US$0.32 in 1Q 2024). Revenue: US$4.87b (down 5.4% from 1Q 2024). Net income: US$11.0m (down 93% from 1Q 2024). Profit margin: 0.2% (down from 3.1% in 1Q 2024). Revenue missed analyst estimates by 5.3%. Earnings per share (EPS) also missed analyst estimates by 91%. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance. Duyuru • Apr 16
Nutrien Ltd. to Report Q1, 2025 Results on May 07, 2025 Nutrien Ltd. announced that they will report Q1, 2025 results After-Market on May 07, 2025 Upcoming Dividend • Mar 24
Upcoming dividend of US$0.55 per share Eligible shareholders must have bought the stock before 31 March 2025. Payment date: 10 April 2025. The company is paying out more than 100% of its profits and is paying out 77% of its cash flow. Trailing yield: 4.2%. Lower than top quartile of American dividend payers (4.7%). Higher than average of industry peers (2.2%). Duyuru • Feb 24
Nutrien Ltd., Annual General Meeting, May 07, 2025 Nutrien Ltd., Annual General Meeting, May 07, 2025. Declared Dividend • Feb 23
Fourth quarter dividend of US$0.55 announced Shareholders will receive a dividend of US$0.55. Ex-date: 31st March 2025 Payment date: 10th April 2025 Dividend yield will be 4.1%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (158% earnings payout ratio). However, it is covered by cash flows (77% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 76% to bring the payout ratio under control. EPS is expected to grow by 77% over the next 3 years, which should be enough to bring the dividend into a sustainable range. Duyuru • Feb 21
Nutrien Ltd. Provides Sales Volume Guidance for the Year 2024 Nutrien Ltd. provided sales volume guidance for the year 2024. For the year, the company expects Potash sales volume guidance of 13.6 to 14.4 million tonnes is consistent with the global shipments outlook and accounts for some uncertainty regarding the possible imposition and related impact of US tariffs, as well as global supply availability. Nitrogen sales volume guidance of 10.7 to 11.2 million tonnes assumes continued reliability improvements and higher operating rates at the North American plants. Phosphate sales volume guidance of 2.35 to 2.55 million tonnes assumes lower production at the White Springs facility in the first half of 2025 and improved operating rates in the second half compared to the prior year. Reported Earnings • Feb 20
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: US$1.36 (down from US$2.53 in FY 2023). Revenue: US$25.0b (down 11% from FY 2023). Net income: US$674.0m (down 46% from FY 2023). Profit margin: 2.7% (down from 4.5% in FY 2023). Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 1.2%. Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Duyuru • Feb 20
Nutrien Ltd. Declares Quarterly Dividend, Payable on April 10, 2025 Nutrien Ltd. announced that its Board of Directors declared a quarterly dividend of USD 0.545 per share payable on April 10, 2025 to shareholders of record on March 31, 2025. This represents an approximately 1% increase from the prior dividend declared on November 6, 2024 and equates to an annualized dividend of USD 2.18 per share. Duyuru • Jan 31
Nutrien Ltd. to Report Q4, 2024 Results on Feb 19, 2025 Nutrien Ltd. announced that they will report Q4, 2024 results After-Market on Feb 19, 2025 Upcoming Dividend • Dec 24
Upcoming dividend of US$0.54 per share Eligible shareholders must have bought the stock before 31 December 2024. Payment date: 17 January 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.9%. Within top quartile of American dividend payers (4.5%). Higher than average of industry peers (2.1%). Duyuru • Nov 12
Jarden Reportedly Tapped for Incitec Pivot Fertiliser Sale Incitec Pivot Limited (ASX:IPL)'s freshly appointed management has brought in a new investment bank to handle the sale of the distribution arm of its fertiliser business as looks to clear the decks and focus on its future as a mining explosives play. The move to break up the fertiliser unit and sell off the distribution arm was first flagged by DataRoom and announced when the company delivered its annual result on 11 November 2024. It came as the company wiped $941 million off the valuation of the Australian Incitec Pivot fertiliser division. The bank being added to the ticket is Jarden. The move comes as new boss Mauro Neves de Moraes takes over. UBS and Macquarie Capital have previously made efforts to sell the fertiliser business and Macquarie still has a role. This time, though, it appears that the group is motivated to move it off its books and look to a future focused on its more successful commercial explosives operation Dyno Nobel, so it is expected to take a realistic approach to price. Former Incitec Pivot management held out for top dollar when trying to sell its fertiliser unit twice before, and opposed a business break-up. Most buyers were keen to buy the distribution arm and few were interested in taking on the more problematic manufacturing operation. But now, with distribution available separately, the sale process is likely to involve plenty of competitive tension. Australian listed trade buyers like Elders Limited (ASX:ELD) and Ridley Corporation Limited (ASX:RIC) and global strategics like The Mosaic Company (NYSE:MOS), CF Industries Holdings, Inc. (NYSE:CF) and Nutrien Ltd. (TSX:NTR), which has a major Australian presence, will be going head to head with private equity firms like Pacific Equity Partners and BGH Capital, which have been sounded out by investment bankers in recent months. It's clear the market is in favour of the decision, with shares closing higher, despite a thumping $311 million loss and an overall $1 billion writedown to the fertiliser unit. The writedown included $100m for its US operations Most of the rest was linked to the Australian manufacturing operations. The sale process will get going in earnest early next year. The book value is now $414.3 million, compared to more than $1 billion in the past. Private equity in the past has put forward offers of less than $500 million for the fertiliser business, but that was when manufacturing was also part of the picture, although they will be still keen to snap up the operation at an opportunistic price. Declared Dividend • Nov 10
Third quarter dividend of US$0.54 announced Shareholders will receive a dividend of US$0.54. Ex-date: 31st December 2024 Payment date: 17th January 2025 Dividend yield will be 4.5%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (145% earnings payout ratio). However, it is well covered by cash flows (46% cash payout ratio). The dividend has increased by an average of 4.4% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 61% to bring the payout ratio under control. EPS is expected to grow by 68% over the next 3 years, which is sufficient to bring the dividend into a sustainable range. Reported Earnings • Nov 07
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: EPS: US$0.036 (down from US$0.15 in 3Q 2023). Revenue: US$5.09b (down 5.3% from 3Q 2023). Net income: US$18.0m (down 76% from 3Q 2023). Profit margin: 0.4% (down from 1.4% in 3Q 2023). Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) also missed analyst estimates by 91%. Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Duyuru • Oct 11
Nutrien Ltd. to Report Q3, 2024 Results on Nov 06, 2024 Nutrien Ltd. announced that they will report Q3, 2024 results After-Market on Nov 06, 2024 Upcoming Dividend • Sep 20
Upcoming dividend of US$0.54 per share Eligible shareholders must have bought the stock before 27 September 2024. Payment date: 18 October 2024. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.6%. Within top quartile of American dividend payers (4.3%). Higher than average of industry peers (1.9%). Declared Dividend • Aug 11
Second quarter dividend of US$0.54 announced Shareholders will receive a dividend of US$0.54. Ex-date: 27th September 2024 Payment date: 18th October 2024 Dividend yield will be 4.7%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (134% earnings payout ratio). However, it is well covered by cash flows (40% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 49% to bring the payout ratio under control. EPS is expected to grow by 56% over the next 3 years, which is sufficient to bring the dividend into a sustainable range. Duyuru • Aug 08
Nutrien Ltd. Announces Chief Financial Officer Changes Nutrien Ltd. announces the appointment of Mark Thompson as Chief Financial Officer, effective August 26, 2024. In alignment with Nutrien's succession plan, Mr. Thompson succeeds Pedro Farah, who will remain with Nutrien in an advisory capacity until his departure on December 31, 2024. Mr. Thompson has been with the Company since 2011, currently serving as Executive Vice President and Chief Commercial Officer. Prior to his current position he held numerous executive and senior leadership roles across the company, including Chief Strategy & Sustainability Officer, Chief Corporate Development & Strategy Officer, and Vice President of Business Development for Nutrien’s Retail business. He earned his Bachelor of Commerce (Finance) and Bachelor of Arts degrees from the University of Saskatchewan and holds the Chartered Financial Analyst (CFA) designation. Reported Earnings • Aug 08
Second quarter 2024 earnings: EPS and revenues miss analyst expectations Second quarter 2024 results: EPS: US$0.78 (down from US$0.89 in 2Q 2023). Revenue: US$9.92b (down 13% from 2Q 2023). Net income: US$385.0m (down 13% from 2Q 2023). Profit margin: 3.9% (in line with 2Q 2023). Revenue missed analyst estimates by 7.6%. Earnings per share (EPS) also missed analyst estimates by 65%. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 10% per year. Duyuru • Aug 08
Nutrien Ltd. Announces the Appointment of Mark Thompson as Executive Vice President, Effective August 26, 2024 Nutrien Ltd. announced the appointment of Mark Thompson as Executive Vice President, effective August 26, 2024. Mr. Thompson has been with the Company since 2011, currently serving as Executive Vice President and Chief Commercial Officer. Prior to his current position he held numerous executive and senior leadership roles across the company, including Chief Strategy & Sustainability Officer, Chief Corporate Development & Strategy Officer, and Vice President of Business Development for Nutrien’s Retail business. He earned his Bachelor of Commerce (Finance) and Bachelor of Arts degrees from the University of Saskatchewan and holds the Chartered Financial Analyst (CFA) designation. Duyuru • Jun 18
Nutrien Ltd. to Report Q2, 2024 Results on Aug 07, 2024 Nutrien Ltd. announced that they will report Q2, 2024 results on Aug 07, 2024 Buy Or Sell Opportunity • Jun 11
Now 21% undervalued The stock has been flat over the last 90 days, currently trading at US$53.20. The fair value is estimated to be US$67.02, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.5% over the last 3 years. Earnings per share has grown by 8.6%. For the next 3 years, revenue is forecast to grow by 1.9% per annum. Earnings are also forecast to grow by 16% per annum over the same time period. Declared Dividend • May 12
First quarter dividend of US$0.54 announced Shareholders will receive a dividend of US$0.54. Ex-date: 28th June 2024 Payment date: 19th July 2024 Dividend yield will be 3.7%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (124% earnings payout ratio). However, it is well covered by cash flows (37% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 38% to bring the payout ratio under control. EPS is expected to grow by 38% over the next 3 years, which should be enough to bring the dividend into a sustainable range. Duyuru • May 10
Nutrien Ltd. Approves the Election of Julie A. Lagacy as Director Nutrien Ltd. at its annual meeting of shareholders held on May 8, 2024 approved the election of Julie A. Lagacy as Director. Reported Earnings • May 09
First quarter 2024 earnings: EPS misses analyst expectations First quarter 2024 results: EPS: US$0.32 (down from US$1.14 in 1Q 2023). Revenue: US$5.15b (down 13% from 1Q 2023). Net income: US$158.0m (down 72% from 1Q 2023). Profit margin: 3.1% (down from 9.7% in 1Q 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 19%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Duyuru • May 09
Nutrien Ltd. Declares Quarterly Dividend, Payable on July 19, 2024 Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.54 per share payable on July 19, 2024, to shareholders of record on June 28, 2024. Duyuru • Apr 15
Nutrien Reportedly Seeks an Exit from its Retail Assets in Argentina, Chile and Uruguay Canadian fertiliser giant Nutrien Ltd. (TSX:NTR) is seeking an exit from its retail assets in Argentina, Chile and Uruguay, Reuters reported citing a statement from the company. The move is said to be aimed at simplifying the company’s business and concentrating on key markets, such as Brazil. Duyuru • Apr 11
Nutrien Ltd. to Report Q1, 2024 Results on May 08, 2024 Nutrien Ltd. announced that they will report Q1, 2024 results After-Market on May 08, 2024 Upcoming Dividend • Mar 20
Upcoming dividend of US$0.54 per share Eligible shareholders must have bought the stock before 27 March 2024. Payment date: 11 April 2024. Payout ratio is on the higher end at 84%, however this is supported by cash flows. Trailing yield: 4.0%. Lower than top quartile of American dividend payers (4.7%). Higher than average of industry peers (1.9%). Declared Dividend • Feb 25
Fourth quarter dividend of US$0.54 announced Shareholders will receive a dividend of US$0.54. Ex-date: 27th March 2024 Payment date: 11th April 2024 Dividend yield will be 4.0%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is covered by both earnings (84% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. EPS is expected to grow by 34% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Duyuru • Feb 24
Nutrien Ltd., Annual General Meeting, May 08, 2024 Nutrien Ltd., Annual General Meeting, May 08, 2024. Duyuru • Feb 22
Nutrien Ltd. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023 Nutrien Ltd. reported impairment charges for the fourth quarter ended December 31, 2023. For the quarter, the company recognized a $76 million non-cash impairment in Nitrogen segment relating to Trinidad property, plant and equipment due to a new natural gas contract and the resulting outlook for higher expected natural gas costs and constrained near-term availability. Reported Earnings • Feb 22
Full year 2023 earnings: EPS misses analyst expectations Full year 2023 results: EPS: US$2.53 (down from US$14.23 in FY 2022). Revenue: US$28.1b (down 24% from FY 2022). Net income: US$1.26b (down 84% from FY 2022). Profit margin: 4.5% (down from 21% in FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 25%. Revenue is forecast to stay flat during the next 3 years compared to a 4.4% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Duyuru • Jan 24
Nutrien Ltd. to Report Q4, 2023 Results on Feb 21, 2024 Nutrien Ltd. announced that they will report Q4, 2023 results After-Market on Feb 21, 2024 Upcoming Dividend • Dec 21
Upcoming dividend of US$0.53 per share at 3.8% yield Eligible shareholders must have bought the stock before 28 December 2023. Payment date: 12 January 2024. Payout ratio is a comfortable 47% and this is well supported by cash flows. Trailing yield: 3.8%. Lower than top quartile of American dividend payers (4.5%). Higher than average of industry peers (2.0%). Reported Earnings • Nov 02
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Third quarter 2023 results: EPS: US$0.15 (down from US$2.95 in 3Q 2022). Revenue: US$5.37b (down 33% from 3Q 2022). Net income: US$75.0m (down 95% from 3Q 2022). Profit margin: 1.4% (down from 20% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 6.4%. Earnings per share (EPS) also missed analyst estimates by 72%. Revenue is forecast to stay flat during the next 3 years compared to a 4.1% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Duyuru • Nov 02
Nutrien Ltd. Declares Quarterly Dividend, Payable on January 12, 2024 Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.53 per share payable on January 12, 2024, to shareholders of record on December 29, 2023. Duyuru • Oct 06
Nutrien Ltd. to Report Q3, 2023 Results on Nov 01, 2023 Nutrien Ltd. announced that they will report Q3, 2023 results After-Market on Nov 01, 2023